Form D · Pharmaceuticals

Ratio Therapeutics, Inc.

Boston, MA · CIK 0002004792

Offering snapshot reported Jul 31, 2026 · SEC filing

Reported sold
$70M
Offering amount: $70M
Investors reported
57
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 16, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 31, 2026Initial$69,999,974No comparison57SEC filing
Dec 21, 2023Initial$50,675,000No comparison46SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-592775

Source: Form D, filed Jul 31, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John Babich Director
Marc Becker Executive
William Cowan Director
Matthias Friebe Executive
John Garvey Executive
Allan Green Director
Jacob Hesterman Executive
Shawn Hillier Executive
Scott Holbrook Director
Albert Holman Director
John W. Hoppin Director, Executive
Brandon Ingersoll Director
Scott Mac Donald Executive
Reed Malleck Executive
Susan Whoriskey Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
One Design Center Place Suite 19 601
Boston, MA, 02210
Phone: 617-371-8898